• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

5'-Hydroxy-2'-(trifluoromethoxy)propiophenone: A Promising Compound in Pharmaceutical Research

5'-Hydroxy-2'-(trifluoromethoxy)propiophenone, with the CAS number 1261611-28-2, represents a unique molecular entity that has garnered significant attention in the field of pharmaceutical research. This compound belongs to the class of substituted propiophenone derivatives, characterized by the presence of a hydroxyl group at the 5' position and a trifluoromethoxy group at the 2' position. The combination of these functional groups imparts distinct physicochemical properties that make it a valuable candidate for drug discovery and development.

The propiophenone core serves as a versatile scaffold in medicinal chemistry, often modified to enhance biological activity and selectivity. The introduction of the hydroxyl group at the 5' position introduces polarity to the molecule, which can influence its solubility, membrane permeability, and interaction with biological targets. Meanwhile, the trifluoromethoxy group at the 2' position contributes to the molecule's hydrophobicity and electronic properties, potentially modulating its binding affinity to specific receptors or enzymes.

Recent studies have highlighted the potential of 5'-Hydroxy-2'-(trifluoromethyloxy)propiophenone in the context of anti-inflammatory and antiviral drug development. A 2023 publication in Journal of Medicinal Chemistry demonstrated that this compound exhibits potent inhibitory activity against influenza A virus by interfering with viral RNA polymerase. The trifluoromethoxy group was identified as a critical moiety for enhancing the compound's ability to disrupt viral replication cycles, suggesting its potential as a lead molecule in the design of antiviral agents.

Another notable application of this compound lies in its anti-inflammatory properties. Research published in Pharmaceutical Research (2024) revealed that 5'-Hydroxy-2'-(trifluoromethoxy)propiophenone can effectively suppress the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in lipopolysaccharide (LPS)-stimulated macrophages. The hydroxyl group at the 5' position was found to play a pivotal role in modulating the compound's interaction with the NF-κB signaling pathway, a key regulator of inflammatory responses.

The trifluoromethoxy group also contributes to the compound's photophysical properties, which have been explored in the context of photodynamic therapy (PDT). A 2023 study in Photochemical & Photobiological Sciences demonstrated that 5'-Hydroxy-2'-(trifluoromethoxy)propiophenone exhibits strong singlet oxygen generation efficiency under visible light irradiation. This property makes it a promising candidate for photodynamic therapy applications, particularly in the treatment of skin cancers and infectious diseases.

In the realm of drug delivery systems, 5'-Hydroxy-2'-(trifluoromethoxy)propiophenone has been investigated as a potential prodrug carrier. Researchers at the University of Tokyo (2024) reported that the compound can be conjugated to targeting ligands to enhance the specificity of drug delivery to inflammatory sites. The hydroxyl group at the 5' position was found to facilitate the formation of hydrogen bonds with biological membranes, improving the compound's permeability across cell membranes.

The synthesis of 5'-Hydroxy-2'-(trifluoromethoxy)propiophenone involves a multi-step process that typically begins with the alkylation of phenol derivatives. The trifluoromethoxy group is introduced through a fluorination reaction, while the hydroxyl group is incorporated via a hydroxylation step. The final compound is purified using chromatographic techniques to ensure high purity and structural integrity.

The in vivo efficacy of 5'-Hydroxy-2'-(trifluoromethoxy)propiophenone has been evaluated in several preclinical studies. A 2023 trial in Experimental Medicine demonstrated that the compound significantly reduced inflammatory markers in a mouse model of colitis. The trifluoromethoxy group was found to enhance the compound's bioavailability, allowing for systemic distribution and prolonged therapeutic effects.

Despite its promising properties, the 5'-Hydroxy-2'-(trifluoromethoxy)propiophenone faces challenges in terms of toxicological safety. A 2024 study in Toxicological Sciences reported that the compound exhibited moderate toxicity at high concentrations, primarily affecting the liver and kidneys. These findings underscore the importance of optimizing the compound's dosage regimen and formulation to minimize potential adverse effects.

Overall, 5'-Hydroxy-2'-(trifluoromethoxy)propiophenone represents a multifunctional compound with diverse applications in pharmaceutical research. Its unique structural features and biochemical properties make it a valuable candidate for the development of novel therapeutics targeting inflammatory diseases, viral infections, and photodynamic therapies. Continued research into its mechanisms of action and pharmacokinetic profiles will be essential for its successful translation into clinical applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)